Table I.
Total no. subjects = 1,478 | No. (%) for categorical variables |
---|---|
mean±SD for continuous variables | |
Gender | |
Male | 709(48.0) |
Female | 769(52.0) |
Study sites | |
US & Canada | 618(41.8) |
Northern_Europe | 430(29.1) |
Southern_Europe | 265(17.9) |
UK & Australia | 165(11.2) |
CHDa | |
No | 637(43.1) |
Yes | 307(20.8) |
Missing | 534(36.2) |
Deletion type | |
AD | 1353(91.5) |
A+-D | 17(1.2) |
AC | 27(1.8) |
AB | 74(5) |
BD | 7(0.5) |
Age | 15.9±9.9 |
FSIQb | 72.41±13.7 |
VIQc | 75.91±14.5 |
PIQd | 73.01±13.7 |
CHD, congenital heart disease, is defined as subjects with Tetralogy of Fallot (TOF), Persistent Truncus Arteriosus (PTA) or Interrupted Aortic Arch Type B (IAAB);
Full scale IQ;
Verbal IQ,
Performance IQ.